Gene Query: ULK3

Dataset Description Geneva Score
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 35.1
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 24.97
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 24.16
Crizotinib v. DMSO in SW480 cells 21.79
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 20.68
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 17.88
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 16.27
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 15.15
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 15.15
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 14.13
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 13.84
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 13.61
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 13.43
mRNA expression profile of Lymphocytes by high-throuput sequencing 13.26
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 13.25
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 12.95
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 12.64
Genome wide expression change in LCC2 and MCF-7 cells 12.56
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 12.55
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 12.55
Active translatome profiling with RiboLace in MCF7 cells 12.38
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 12.29
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 12.23
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 11.84
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 11.83
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 11.71
11.19
Genome wide expression change by RNF168 knocking down in MCF-7 cells 11.14
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 11.06
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 11.05
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 10.94
A transcriptome-wide divergence in protein translation scales with LIN28B expression 10.93
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 10.93
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 10.83
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 10.49
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 10.24
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 9.95
Paxillin regulates genomic networks in prostate cancer [PC3] 9.94
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 9.83
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 9.82
Characterization of parental and rociletinib-resistant derived H1975 cell lines 9.51
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 9.38
DART-seq: an antibody-free method for global m6A detection 9.26
Novel Targeting of Transcription and Metabolism in Glioblastoma 9.15
Stem and effector CD8 T-cells from human cancers 9.15
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 9.14
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 9.14
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 9.09
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 9.07
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 9.07
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 9.07
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 9.02
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 8.91
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 8.91
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 8.9
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 8.78
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 8.58
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 8.58
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 8.54
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 8.45
Characterization of human ILC2 subsets 8.32
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 8.31
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 8.2
RNA-seq in transgenic cells 8.01
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 8.0
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 7.98
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 7.94
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 7.94
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 7.88
Co-regulation of splicing by Rbfox1 and hnRNP M 7.88
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 7.84
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 7.73
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 7.64
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 7.53
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 7.52
quanTIseq: quantifying immune contexture of human tumors 7.51
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 7.51
Gene expression changes after LOC550643 silencing 7.46
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 7.44
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 7.35
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 7.32
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 7.32
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 7.27
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 7.26
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 7.26
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 7.26
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 7.24
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 7.2
A novel target of EZH1/2 for treatment of mantle cell lymphoma 7.13
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 7.12
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 7.02
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 7.01
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 7.01
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 6.94
Global analysis of alternative splicing regulated by RBM10 6.85
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 6.77
Gene expression signatures of innate lymphoid cells from human blood 6.77
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 6.74
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 6.71
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 6.65
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 6.65
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 6.64
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 6.56
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 6.56
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 6.42
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 6.38
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 6.35
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 6.31
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 6.27
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 6.2
Transcriptional responses of human insulinoma cells to acute cytokine exposure 6.19
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 6.16
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 6.16
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 6.14
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 6.12
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 6.07
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 6.02
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 6.01
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 5.99
Controlling for gene expression changes in transcription factor protein networks. 5.96
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 5.92
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 5.91
Effect of PBK knockdown on C4-2 cell transcriptome 5.9
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 5.86
ETV7 and interferon response 5.86
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 5.85
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 5.83
SNHG5 siRNA knock down in HCT116 cells 5.82
Transcriptome profiling of Normal and Cancerous Prostate Cells 5.82
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 5.74
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 5.71
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 5.71
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 5.66
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 5.65
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 5.64
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 5.64
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 5.59
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 5.57
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 5.54
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 5.52
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 5.52
Transcriptome of activated human and mouse MAIT cells 5.52
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 5.5
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 5.47
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 5.47
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 5.46
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 5.46
NHLRC1 re-expression in cancer cells 5.46
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 5.45
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 5.42
Dtx3L and Androgen Signaling in Prostate Cancer 5.4
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 5.39
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 5.39
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 5.39
Gene expression changes associated with resistance to tagraxofusp (SL-401) 5.34
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 5.3
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 5.3
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 5.24
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 5.23
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 5.23
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 5.15
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 5.14
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 5.11
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 5.11
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 5.08
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 5.06
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 5.05
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 5.04
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 5.02
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 5.02
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 5.02
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 4.99
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 4.96
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 4.96
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 4.94
Epigenomic landscape during organ formation in human early embryos 4.92
STX4 Over-Expression in Human islets 4.89
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 4.85
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 4.85
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 4.78
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 4.77
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 4.77
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 4.77
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 4.75
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 4.74
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 4.73
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 4.68
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 4.67
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 4.66
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 4.66
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 4.63
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 4.62
ENCODE Cold Spring Harbor Labs Long RNA-seq 4.6
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 4.59
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 4.59
Total RNA-seq in ALL-SIL upon JQ1 inhibition 4.57
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 4.57
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 4.55
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 4.54
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 4.51
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 4.49
RNA-seq of MCF10A cells and CAF 4.49
RNA-seq of tumor cells following angiopellosis extravasation 4.49
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 4.44
Induced DNA demethylation, genome instability and transcription 4.43
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 4.43
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 4.42
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 4.39
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 4.39
Functional role of CPPED1 in trophoblasts. 4.37
Biological effect of chronic mistranslation in mammalian cells 4.24
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 4.23
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 4.23
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 4.23
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 4.21
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 4.19
circRNA-sequencing 4.14
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 4.11
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 4.09
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 4.07
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 4.06
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 4.06
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 4.05
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 4.04
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 4.01
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 3.99
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 3.95
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 3.94
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 3.93
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 3.9
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 3.9
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 3.9
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 3.88
Genetic-to-epigenetic Therapy for Pancreatic Cancer 3.87
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 3.85
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 3.84
Transcriptional profiles of normal human mature B cells 3.84
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 3.84
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 3.83
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 3.81
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 3.79
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 3.79
RNAseq of IL-36 stimulated primary human keratinocytes 3.77
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 3.73
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 3.72
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 3.69
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 3.58
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 3.57
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 3.54
Gene expression analysis upon mtDNA depletion 3.52
Gene expression analysis upon mtDNA depletion [RNA-seq] 3.52
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 3.5
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 3.5
Identification of renal resident macrophages across species [C1] 3.49
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 3.47
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 3.45
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 3.45
Expression and functions of long noncoding RNAs during human T helper cell differentiation 3.36
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 3.34
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 3.29
Gene expression analysis in response to hypoxic pathway inhibition 3.25
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 3.24
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 3.23
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 3.22
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 3.22
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 3.19
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 3.18
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 3.17
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 3.17
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 3.17
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 3.15
Transcriptomes in healthy and CHB fetal hearts 3.14
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 3.11
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 3.09
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 3.09
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 3.08
Microglia innatly develop within cerebral organoids 3.07
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 2.98
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 2.98
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 2.95
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.94
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 2.93
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 2.93
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 2.91
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 2.91
Role of XRN2 ribonucleolytic activity in RNA metabolism 2.89
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 2.88
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.87
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.87
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 2.86
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 2.8
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 2.79
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 2.78
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 2.77
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 2.77
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 2.74
Gene expression profiling of leukemia cells following asparagine depletion 2.72
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 2.71
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 2.7
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.7
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 2.7
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.7
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 2.69
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 2.68
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 2.66
Transciptomic profiling of human fetal lung samples 2.6
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 2.56
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 2.56
RNAseq Study in CC-671 Treated Cal-51 Cells 2.55
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 2.54
N6-methyladenine DNA Modification in Glioblastoma 2.54
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 2.53
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 2.53
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.51
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 2.51
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 2.49
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 2.49
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 2.48
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 2.44
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 2.44
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.43
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 2.4
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 2.4
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 2.4
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 2.38
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.33
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 2.32
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 2.31
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 2.31
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 2.26
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 2.26
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 2.26
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 2.22
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 2.21
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 2.2
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 2.17
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 2.09
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 2.07
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 2.05
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 2.02
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 2.0
Conservative alteration of chromosomal expression pattern across human solid tumor types 1.99
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 1.99
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 1.96
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 1.96
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 1.95
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 1.95
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.94
Interaction between mitoNEET and NAF-1 in cancer cells 1.91
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 1.91
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 1.85
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 1.77
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 1.77
mRNA sequencing of oropharyngeal cancer cell lines 1.73
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.72
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.72
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.72
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.72
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 1.7
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 1.69
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 1.69
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 1.69
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.68
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 1.67
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 1.67
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.66
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 1.66
RNA Seq of Alagille liver biopsies 1.65
Alagille_Nodder 1.65
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 1.6
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.57
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.54
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 1.53
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.52
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.52
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 1.49
p63 controls the enhancer landscape during keratinocyte differentiation 1.47
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 1.47
Functional Haploid Human Oocytes Generated from Polar Body Genomes 1.47
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.47
Gene expression analysis of human hepatocellular cancers 1.46
mRNA recovered upon RNF219 IP. [RNA-IP] 1.45
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.44
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 1.44
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 1.44
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 1.44
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 1.43
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 1.43
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.42
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 1.42
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.41
BACH2 in human plasma cell fate decision 1.35
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 1.32
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 1.32
Targeted enhancer activation by a subunit of the integrator complex 1.31
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 1.29
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 1.28
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 1.26
Functional significance of the HIV-1 Tat signature amino acid residues 1.22
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 1.22
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 1.19
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.19
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 1.19
RNA-seq of SCLC PDX models treated with EP 1.16
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.15
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 1.13
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 1.09
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 1.09
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 1.07
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.07
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 1.07
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 1.06
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 1.05
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 1.05
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.0
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.0
RNA-sequencing 0.99
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.98
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.96
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.96
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 0.96
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.93
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.9
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.9
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.9
Analyses of T-ALL (COG study) 0.9
RNA sequencing of T-ALL (COG study) 0.9
The role of the Calcium-Sensing receptor in colorectal cancer 0.89
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.85
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 0.84
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 0.84
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 0.83
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.81
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 0.8
Zone dependent distinctive gene expression profile of the normal human liver tissue 0.79
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.79
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.79
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 0.78
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.71
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.71
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.69
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.69
Epigenomic conservation of transposable element silencing 0.68
Epigenomic conservation of transposable element silencing [RNA-seq] 0.68
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.68
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 0.68
An acquired vulnerability of drug resistant melanoma with therapeutic potential 0.68
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.68
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.65
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.61
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.61
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.57
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.57
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 0.55
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 0.53
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.53
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.53
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.47
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.46
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 0.44
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 0.44
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.44
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.43
CUREfast: Accelerating research with families 0.42
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.4
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.4
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.39
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 0.36
Identification of a LIF-responsive replication-competent human β cell 0.36
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.34
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.34
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.3
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.29
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 0.25
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 0.25
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 0.23
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 0.23
Expression profiling of converted and control dermal BJ fibroblasts 0.23
Comparative Analysis of Cas9 Activators Across Multiple Species 0.23
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.21
Dermal endothelial cells of type 2 diabetic patients 0.21
Gene Expression Profiling of WT and KDM3A Knocked out Cell 0.2
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 0.2
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.2
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.18
MHC Transcriptomic landscape at haplotype-specific resolution 0.18
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.17
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.15
RNA-seq differential expression studies: more sequence, or more replication? 0.13
Identification of renal resident macrophages across species 0.13
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.13
Gene expression analysis of human adenomas. 0.12
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.12
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.12
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.1
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.08
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.08
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.05
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.03
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation